001 hypertension in pregnancy
TRANSCRIPT
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 1/52
Hypertension in PregnancyHypertension in Pregnancy
N.L. Meyer, M.D.N.L. Meyer, M.D.
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 2/52
Hypertension in PregnancyHypertension in Pregnancy
• Most common medical disorder during pregnancy
•Gestational hypertension – preeclampsia
•70% of HTN in pregnancy
•Wide spectrum
•Mild elevation in BP vs severe hypertensionwith organ dysfunctions
•Acute gestational hypertension
•Preeclampsia
•Eclampsia
•HELLP
•Most common medical disorder during pregnancy•Gestational hypertension – preeclampsia
•70% of HTN in pregnancy•Wide spectrum
•Mild elevation in BP vs severe hypertensionwith organ dysfunctions
• Acute gestational hypertension
•Preeclampsia
•Eclampsia
•HELLP
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 3/52
Hypertension in PregnancyHypertension in Pregnancy
Clinical Findings
Chronic
Hypertension
Gestational
Hypertension Preeclampsia
Onset < 20 weeks Thirdtrimester ≥20 weeks
Degree Mild or severe Mild Mild or severe
Proteinuria Absent Absent Usually present
Uric acid >5.5 mg/dl Rare Absent Usually present
Hemoconcentration Absent Absent Severe disease
Thrombocytopenia Absent Absent Severe disease
Hepatic dysfunction Absent Absent Severe disease
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 4/52
Gestational HypertensionGestational Hypertension
•Systolic BP ≥140 and/or diastolic ≥90 on atleast 2 occasions at least 6 hours apart after 20
weeks in women known to be normotensivebefore pregnancy and before 20 weeks
gestation
•BP recordings should be no more than 7 days
apart
•Severe gestational hypertension
•Sustained elevations in systolic BP ≥160
and/or diastolic BP ≥110 for 6 hours
•Systolic BP ≥140 and/or diastolic ≥90 on atleast 2 occasions at least 6 hours apart after 20
weeks in women known to be normotensivebefore pregnancy and before 20 weeks
gestation
•BP recordings should be no more than 7 days
apart
•Severe gestational hypertension
•Sustained elevations in systolic BP ≥160
and/or diastolic BP ≥110 for 6 hours
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 5/52
Gestational HypertensionGestational Hypertension
•Most frequent cause of HTN during
pregnancy
•6-17% in healthy nulliparous patients
•2-4% in multiparous patients
•Rates increase
•Previous preeclampsia
•Multifetal gestations
•Most frequent cause of HTN duringpregnancy
•6-17% in healthy nulliparous patients
•2 -4% in multiparous patients
•Rates increase
•Previous preeclampsia
•Multifetal gestations
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 6/52
Gestational HypertensionGestational Hypertension
•Progression
•Gestational age at diagnosis
•50% progression with diagnosis prior to 30
weeks
•Severe hypertension
•Preeclampsia•Eclampsia
•Undiagnosed hypertension
• Progression
•Gestational age at diagnosis
•50% progression with diagnosis prior to 30
weeks
•Severe hypertension
•Preeclampsia
•Eclampsia
• Undiagnosed hypertension
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 7/52
Gestational HypertensionGestational Hypertension
• Most cases develop ≥37 weeks
• Overall outcome similar to or better thannormotensive pregnancies
•Higher gestational age at delivery
•Higher birth weight
• Higher rates of induction
•Higher cesarean section rates
•Most cases develop ≥37 weeks
•Overall outcome similar to or better thannormotensive pregnancies
•Higher gestational age at delivery
•Higher birth weight
•Higher rates of induction
•Higher cesarean section rates
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 8/52
Mild Gestational HypertensionMild Gestational Hypertension
Kuinst(n=396)
Hauth(n=715)
Barton(n=405)
Sibai(n=186)
Gestational age NR 39.7 37.4 39.1
< 37 (%) 5.3 7.0 17.3 5.9
< 34 (%) 1.3 1.0 4.9 1.6
Birth weight (gm) NR 3303 3038 3217
SGA (%) 1.5 6.9 13.8 7.0
< 2500 g (%) 7.1 7.7 23.5 NR
Abruption (%) 0.5 0.3 0.5 0.5
Perinatal death (%) 0.8 0.5 0 0
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 9/52
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 10/52
Mild Gestational HypertensionMild Gestational Hypertension
Maternal Evaluation
•Weekly prenatal visits
•Reporting preeclamptic symptoms
•Laboratory evaluation
•CBC
•Platelets
•LFT's
Maternal Evaluation
•Weekly prenatal visits
•Reporting preeclamptic symptoms
•Laboratory evaluation
•CBC•Platelets
•LFT's
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 11/52
Mild Gestational HypertensionMild Gestational Hypertension
•Amniotic fluid
•Estimated weight
•Weekly nonstress testing
• Amniotic fluid
•Estimated weight
•Weekly nonstress testing
Fetal EvaluationFetal Evaluation
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 12/52
Mild Gestational HypertensionMild Gestational Hypertension
•Salt restriction – not indicated
•Restricted activity – not indicated
•Antihypertensive medication – not indicated
•Continue to term
•Absence of progression
•Seizure prophylaxis – not indicated
•Salt restriction – not indicated
•Restricted activity – not indicated
• Antihypertensive medication – not indicated
•Continue to term
• Absence of progression
•Seizure prophylaxis – not indicated
ManagementManagement
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 13/52
Severe Gestational HypertensionSevere Gestational Hypertension
•Increased maternal and perinatal morbidity
•Outcomes similar to severe preeclampsia
•Abruptio placentae
•Preterm delivery
•< 37 weeks
•< 35 weeks•SGA infants
•Manage as if they had severe preeclampsia
•Increased maternal and perinatal morbidity
•Outcomes similar to severe preeclampsia
• Abruptio placentae
•Preterm delivery
•< 37 weeks
•< 35 weeks•SGA infants
•Manage as if they had severe preeclampsia
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 14/52
Severe Gestational HTN vs Severe PreeclampsiaSevere Gestational HTN vs Severe Preeclampsia
Outcome Relative risk 95% CI
Delivery <37 wk 0.81 0.53-1.24
Delivery <35 wk 0.7 0.32-1.56
SGA infant 1.83 0.56-5.71
Abruption 0.63 0.07-5.69
LGA infant 1.87 0.28-12.49
NICU admissions 0.55 0.23-1.31
RDS 0.75 0.21-2.63
Buchbinder et al AJOG 2002;186:66-71Buchbinder et al AJOG 2002;186:66-71
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 15/52
PreeclampsiaPreeclampsia
•Hypertension unique to human pregnancy
•Rarely reported in primates
•Incidence
•3-7% in nulliparas
•0.8-5% in multiparas
•Significantly increased in multigestations
•Hypertension unique to human pregnancy
•Rarely reported in primates
•Incidence
•3-7% in nulliparas
•0.8-5% in multiparas
•Significantly increased in multigestations
Ri k F
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 16/52
Risk FactorsRisk Factors
• Nulliparity
• Family history
• Obesity• Multifetal gestation
• Previous preeclampsia
• Previous poor outcome
• IUFD
• IUGR
• Abruption
• Nulliparity
• Family history
• Obesity• Multifetal gestation
• Previous preeclampsia
• Previous poor outcome
• IUFD
• IUGR
• Abruption
• Preexisting medical conditions
• CHTN
• Renal disease• Diabetes
• Thrombophilias
• APAS
• Protein S deficiency
• Protein C deficiency
• Factor V Leiden
• Abnormal dopplers
• Preexisting medical conditions
• CHTN
• Renal disease• Diabetes
• Thrombophilias
• APAS
• Protein S deficiency
• Protein C deficiency
• Factor V Leiden
• Abnormal dopplers
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 17/52
PreeclampsiaPreeclampsia
•Gestational hypertension plus proteinuria
•≥300 mg/24 hours
•Classic triad•Hypertension
•Proteinuria
•Edema
•Gestational hypertension plus proteinuria
•≥300 mg/24 hours
•Classic triad•Hypertension
•Proteinuria
•Edema
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 18/52
HypertensionHypertension
•Systolic blood pressure of ≥140 mm or diastolicblood pressure of ≥90 mm after 20 weeks in a
previously normotensive women
• "30 x 15" rule
•↑ 30 mm SBP or 15 mm DBP over baseline
•No longer used
•Gradual rise in BP is seen in most normal
pregnancies•73% of primigravidas demonstrate >15 mm
increase in DBP during pregnancy
•67% with SBP > 30 mm over baseline
•Systolic blood pressure of ≥140 mm or diastolicblood pressure of ≥90 mm after 20 weeks in a
previously normotensive women
• "30 x 15" rule
•↑ 30 mm SBP or 15 mm DBP over baseline
•No longer used
•Gradual rise in BP is seen in most normal
pregnancies•73% of primigravidas demonstrate >15 mm
increase in DBP during pregnancy
•67% with SBP > 30 mm over baseline
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 19/52
HypertensionHypertension
Sensitivity PPV
DPB ≥15 mm 39% 32%
SBP ≥30 mm 22% 33%
Villar and Sibai AJOG 1989;60:419Villar and Sibai AJOG 1989;60:419
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 20/52
HypertensionHypertension
•Korotkoff phase V
•Appropriate size cuff
•Length 1.5 x upper arm circumference
•Bladder encircles > 80% of the arm
•Upright position after ≥ 10 minutes rest•Hospitalized
•Either sitting up or LLR position•Arm level with heart
•No tobacco or caffeine x 30 minutes
•Mercury sphygmomanometer preferred
•Korotkoff phase V
• Appropriate size cuff
•Length 1.5 x upper arm circumference
•Bladder encircles > 80% of the arm
•Upright position after ≥ 10 minutes rest•Hospitalized
•Either sitting up or LLR position• Arm level with heart
•No tobacco or caffeine x 30 minutes
•Mercury sphygmomanometer preferred
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 21/52
EdemaEdema
•No longer considered part of the diagnosis
•Neither sufficient nor necessary to confirm
•Common finding in normal pregnancies
•1/3 of eclamptic women do not developedema
•No longer considered part of the diagnosis
•Neither sufficient nor necessary to confirm
•Common finding in normal pregnancies
•1/3 of eclamptic women do not developedema
ProteinuriaProteinuria
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 22/52
ProteinuriaProteinuria
•≥300 mg/ 24 hours
•30 mg/dL or ≥1+ on dipstick on at least 2 random
samples at least 6 hours apart but <7 days apart
•Dipstick correlates poorly with protein in a 24-hrcollection*
•1+ has PPV of 92% for ≥300 mg /24-hr
•Negative to trace has a NPV of only 34%
•66% have > 300 mg /24-hrs
•Cannot exclude significant proteinuria
•3+ to 4+ have PPV of 36%
•Cannot confirm significant proteinuria
•≥300 mg / 24 hours
•30 mg/dL or ≥1+ on dipstick on at least 2 random
samples at least 6 hours apart but <7 days apart
•Dipstick correlates poorly with protein in a 24-hrcollection*
•1+ has PPV of 92% for ≥300 mg / 24-hr
•Negative to trace has a NPV of only 34%
•66% have > 300 mg / 24-hrs
•Cannot exclude significant proteinuria
•3+ to 4+ have PPV of 36%
•Cannot confirm significant proteinuria* Meyer et al AJOG 1994;170:137-41* Meyer et al AJOG 1994;170:137-41
P t i iProteinuria
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 23/52
ProteinuriaProteinuria
Urine protein /24hrs Neg Tr 1+ 2+ 3+ 4+<300 21 21 9 3 3 0
300-4999 37 44 42 38 22 24
≥5000 0 0 2 7 10 17
Meyer et al AJOG 1994;170:137-41Meyer et al AJOG 1994;170:137-41
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 24/52
ProteinuriaProteinuria
Dipstick mg / 24-hrs Sensitivity Specificity PPV NPV
> 1+ ≥300 67 74 92 34
> 3+ ≥5000 75 81 36 96
Meyer et al AJOG 1994;170:137-41Meyer et al AJOG 1994;170:137Meyer et al AJOG 1994;170:137--4141
ProteinuriaProteinuria
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 25/52
ProteinuriaProteinuria
•Can preeclampsia occur withoutproteinuria?
•Consider preeclampsia when gestational
hypertension is associated with other
symptoms
•Persistent cerebral symptoms•Epigastric or right upper quadrant pain
with nausea and vomiting•Thrombocytopenia
•Abnormal liver enzymes•IUGR
•Can preeclampsia occur withoutproteinuria?
•Consider preeclampsia when gestational
hypertension is associated with other
symptoms
•Persistent cerebral symptoms•Epigastric or right upper quadrant pain
with nausea and vomiting•Thrombocytopenia
• Abnormal liver enzymes•IUGR
Severe PreeclampsiaSevere Preeclampsia
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 26/52
Severe PreeclampsiaSevere Preeclampsia
• Severe gestational hypertension
associated with abnormal proteinuria
• SBP ≥160 mm or DBP ≥110 mm on 2
occasions >6 hours apart at bed rest
• Hypertension in association with severe
proteinuria
• ≥ 5 g /24 hours
• Severe gestational hypertension
associated with abnormal proteinuria
• SBP ≥160 mm or DBP ≥110 mm on 2
occasions >6 hours apart at bed rest
• Hypertension in association with severe
proteinuria
• ≥ 5 g /24 hours
Severe PreeclampsiaSevere Preeclampsia
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 27/52
Severe PreeclampsiaSevere Preeclampsia
•Multiorgan involvement•Pulmonary edema
•Seizures•Oliguria
•< 500 mL / 24 hours
•Thrombocytopenia
•<100,000/mm3
•Abnormal LFT with persistent RUQ or
epigastric pain
•Persistent severe CNS symptoms
• Multiorgan involvement•Pulmonary edema
•Seizures
•Oliguria
•< 500 mL / 24 hours
•Thrombocytopenia
•<100,000/mm3
• Abnormal LFT with persistent RUQ or
epigastric pain
•Persistent severe CNS symptoms
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 28/52
Superimposed PreeclampsiaSuperimposed Preeclampsia
•New onset proteinuria complicating
hypertension prior to 20 weeks gestation
•Sudden increase in proteinuria
•Sudden increase in hypertension•HELLP syndrome
•CHTN with HA, scotomata or epigastric
pain
•New onset proteinuria complicating
hypertension prior to 20 weeks gestation
•Sudden increase in proteinuria
•Sudden increase in hypertension•HELLP syndrome
•CHTN with HA, scotomata or epigastric
pain
ManagementManagement
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 29/52
ManagementManagement
•Delivery is the only cure
•Primary considerations
•Safety of mother
•Delivery of a live, mature newborn
• Immediate delivery vs expectant management
•Severity of disease process•Maternal / fetal status at initial evaluation
•Gestational age•Labor
•Bishop score
•Maternal desire
•Delivery is the only cure
•Primary considerations
•Safety of mother
•Delivery of a live, mature newborn
• Immediate delivery vs expectant management
•Severity of disease process•Maternal / fetal status at initial evaluation
•Gestational age•Labor
•Bishop score
•Maternal desire
Mild P l i M tMild Preeclampsia Management
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 30/52
Mild Preeclampsia - ManagementMild Preeclampsia - Management
•Mild preeclampsia at term with favorable cervix•Delivery
•Unfavorable cervix ≥37 weeks - ? Cervical ripening•Delivery ≥34 weeks
•Progressive labor •ROM
•Abnormal testing•IUGR
•Deliver by 40 weeks even with unfavorable
conditions
•Mild preeclampsia at term with favorable cervix•Delivery
•Unfavorable cervix ≥37 weeks - ? Cervical ripening•Delivery ≥34 weeks
•Progressive labor •ROM
• Abnormal testing
•IUGR
•Deliver by 40 weeks even with unfavorable
conditions
Mild P l i M tMild Preeclampsia Management
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 31/52
Mild Preeclampsia - ManagementMild Preeclampsia - Management
•Management <37 weeks remains controversial
•Maternal and fetal evaluation?
•Hospitalization vs ambulatory management?
•Antihypertensive medications?
•Bed rest?
•Management <37 weeks remains controversial
•Maternal and fetal evaluation?
•Hospitalization vs ambulatory management?
• Antihypertensive medications?
•Bed rest?
Maternal EvaluationMaternal Evaluation
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 32/52
Maternal EvaluationMaternal Evaluation
•Frequent evaluation for progression of disease
•Lab evaluation•Platelet count
•LFT's
•Renal function
•Urine protein
•Repeat weekly – mild disease, no progression
•Frequent evaluation for progression of disease
•Lab evaluation•Platelet count
•LFT's
•Renal function
•Urine protein
•Repeat weekly – mild disease, no progression
Fetal EvaluationFetal Evaluation
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 33/52
Fetal EvaluationFetal Evaluation
• Weekly antepartum fetal evaluation
•Twice weekly testing with IUGR or oligohydramnios
• Daily fetal movement assessment
•Fetal growth evaluation
•Weekly antepartum fetal evaluation
•Twice weekly testing with IUGR or oligohydramnios
•Daily fetal movement assessment
•Fetal growth evaluation
Outpatient ManagementOutpatient Management
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 34/52
Outpatient ManagementOutpatient Management
•SBP ≤ 150mm / DBP ≤ 100mm
•Urine protein ≤ 1000 mg/24 hours
•Asymptomatic
•Normal LFT's
•Platelets ≥ 1000/mm3
•Daily BP and urinalysis
•Twice weekly evaluation
•Growth and fluid assessment q 3 weeks
•Hospitalize with disease progression
•SBP ≤ 150mm / DBP ≤ 100mm
•Urine protein ≤ 1000 mg/24 hours
• Asymptomatic
•Normal LFT's
•Platelets ≥ 1000/mm3
•Daily BP and urinalysis
•Twice weekly evaluation
•Growth and fluid assessment q 3 weeks
•Hospitalize with disease progression
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 35/52
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 36/52
Magnesium Sulfate ProphylaxisMagnesium Sulfate Prophylaxis
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 37/52
Magnesium Sulfate ProphylaxisMagnesium Sulfate Prophylaxis
•>70 years of use
• Intramuscular (Pritchard) and intravenous (Sibai)
regimes
• "Standard of care" in the US
•10% progression to severe disease withprophylaxis or placebo in 135 women at term*
•12.8% vs 16.8% progression in a recentcontrolled trial of MgSO4 vs placebo**
• >70 years of use
• Intramuscular (Pritchard) and intravenous (Sibai)
regimes
• "Standard of care" in the US
• 10% progression to severe disease withprophylaxis or placebo in 135 women at term*
• 12.8% vs 16.8% progression in a recentcontrolled trial of MgSO4 vs placebo**
*Witlin, Friedman, Sibai AJOG 1997;176:623-7
**Livingston et al Ob Gyn 2003;101:217-220
*Witlin, Friedman, Sibai AJOG 1997;176:623-7
**Livingston et al Ob Gyn 2003;101:217-220
Severe PreeclampsiaSevere Preeclampsia
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 38/52
Severe PreeclampsiaSevere Preeclampsia
•SBP ≥160mm or DBP ≥110mm on 2 occasions 6hours apart at bed rest
•Significant proteinuria (≥5 g/24–hr)
•Oliguria <500 mL/ 24-h
•Cerebral /visual disturbances
•Epigastric pain, nausea, vomiting
•Pulmonary edema, cyanosis
•Abnormal LFT's
•Thrombocytopenia
•IUGR
•SBP ≥160mm or DBP ≥110mm on 2 occasions 6hours apart at bed rest
•Significant proteinuria (≥5 g/24–hr)
•Oliguria <500 mL/ 24-h
•Cerebral/visual disturbances
•Epigastric pain, nausea, vomiting
•Pulmonary edema, cyanosis
• Abnormal LFT's
•Thrombocytopenia
• IUGR
Severe PreeclampsiaSevere Preeclampsia
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 39/52
Severe PreeclampsiaSevere Preeclampsia
•Hospitalization
•MgSO4 prophylaxis
•Antihypertensive medication
•Maintain SBP 140-155mm and DBP 90-105mm
•24-34 weeks
•Steroids for lung maturity
•Maternal assessment
•Fetal assessment
•Hospitalization
•MgSO4 prophylaxis
• Antihypertensive medication
•Maintain SBP 140-155mm and DBP 90-105mm
•24-34 weeks
•Steroids for lung maturity
•Maternal assessment
•Fetal assessment
Antihypertensive Medication Antihypertensive Medication
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 40/52
ypyp
Hydralazine5 mg IV or 10 mg IM. Repeat at 20 minintervals pending response. Repeat prn
when controlled (usually 3 hrs). Max dose
20 mg IV or 30 mg IM.
Labetalol
20 mg IV bolus initially, then 40, 80, 80 mg
every 10 minutes for max 220 mg. Caution
with asthma, CHF.
Nifedipine 10 mg po. Repeat in 30 min if necessary.
Sodium Nitroprusside
HTN unresponsive to other drugs or
hypertensive encephalopathy. 0.25µg/kg/min to max 5 µg/kg/min. Fetal
cyanide toxicity if used >4 hrs.
National High Blood Pressure Education Program Working Group on High Blood
Pressure in Pregnancy. AJOG 2000;183:S1-S22.
National High Blood Pressure Education Program Working Group on High Blood
Pressure in Pregnancy. AJOG 2000;183:S1-S22.
Antihypertensive Therapy Antihypertensive Therapy
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 41/52
• Prevent potential cerebrovascular and cardiovascular
complications
• Encephalopathy, hemorrhage, CHF
• No randomized trials to determine what level to treatto prevent complications
• Recommendations vary
• SBP ≥180mm and DBP ≥110mm
• SBP ≥160 mm or DBP ≥105mm
• MABP ≥130mm
• Sibai Ob Gyn 2003;102:181• Intrapartum – SBP ≥170mm or DBP ≥110mm
• Postpartum or thrombocytopenia – SBP ≥160mm
or DBP ≥105mm
• Prevent potential cerebrovascular and cardiovascular
complications• Encephalopathy, hemorrhage, CHF
• No randomized trials to determine what level to treat
to prevent complications
• Recommendations vary
• SBP ≥180mm and DBP ≥110mm
• SBP ≥160 mm or DBP ≥105mm
• MABP ≥130mm
• Sibai Ob Gyn 2003;102:181• Intrapartum – SBP ≥170mm or DBP ≥110mm
• Postpartum or thrombocytopenia – SBP ≥160mm
or DBP ≥105mm
Severe PreeclampsiaSevere Preeclampsia
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 42/52
•Progressive deterioration in both maternal and
fetal conditions
•Deliver with onset after 34 weeks
• Increased rate of maternal morbidity/mortality•Significant fetal risk
•Delivery prior to 34 weeks
• Imminent eclampsia
•Multiorgan dysfunction
•Severe IUGR
•Suspected abruption
•Non-reassuring fetal testing
•Progressive deterioration in both maternal and
fetal conditions
•Deliver with onset after 34 weeks
• Increased rate of maternal morbidity/mortality•Significant fetal risk
•Delivery prior to 34 weeks
• Imminent eclampsia
•Multiorgan dysfunction
•Severe IUGR
•Suspected abruption
•Non-reassuring fetal testing
Severe Preeclampsia < 34 WeeksSevere Preeclampsia < 34 Weeks
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 43/52
p
•Considerable disagreement•Delivery is definitive therapy
•Delivery may not be optimal for the prematurefetus
•≥34 weeks – deliver
•< 23 weeks – offer termination
•33 - 34 weeks – steroids with delivery after 48-hrs
•23 - 32 weeks gestation• Individualized treatment based on clinicalresponse during the initial 24 hours
observation
•Considerable disagreement
•Delivery is definitive therapy
•Delivery may not be optimal for the premature
fetus
•≥34 weeks – deliver
•< 23 weeks – offer termination
•33 - 34 weeks – steroids with delivery after 48-hrs
•23 - 32 weeks gestation• Individualized treatment based on clinicalresponse during the initial 24 hours
observation
Chronic HypertensionChronic Hypertension
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 44/52
Chronic HypertensionC o c ype te s o
•5% of pregnant women
•Hypertension before the 20th week or before
pregnancy
•Antihypertensive medication prior to pregnancy
•Persistence beyond the usual postpartum period
•Mild chronic hypertension
•≥140 / 90 mm Hg
•Severe chronic hypertension
•≥180 / 110 mm Hg
•5 % of pregnant women•Hypertension before the 20th week or before
pregnancy
• Antihypertensive medication prior to pregnancy
• Persistence beyond the usual postpartum period• Mild chronic hypertension
•≥140 / 90 mm Hg
•Severe chronic hypertension
•≥180 / 110 mm Hg
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 45/52
Chronic HypertensionChronic Hypertension
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 46/52
ypyp
•Risks
•Superimposed preeclampsia
•4.7 – 52% incidence
•Abruption
•Poor perinatal outcome
•IUGR•IUFD
•PTD
•Risks
•Superimposed preeclampsia
•4.7 – 52% incidence
• Abruption
•Poor perinatal outcome
•IUGR•IUFD
•PTD
Low Risk Chronic HTNLow Risk Chronic HTN
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 47/52
•Mild essential hypertension without organ
involvement
•Blood pressure at initial visit regardless of
medication
•BP <180/110 mmHg
•No previous perinatal losses
•Mild essential hypertension without organ
involvement
•Blood pressure at initial visit regardless of
medication
•BP <180/110 mmHg
•No previous perinatal losses
Low Risk Chronic HTNLow Risk Chronic HTN
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 48/52
• Usually good perinatal outcome irrespective ofantihypertensive drugs
• 49% ↓ MAP
• 34% with no change in MAP• Most poor outcomes were related to superimposedpreeclampsia
• Discontinue antihypertensive meds
• Treat BP >160/110 mmHg to keep DBP ≤105 mmHg
• In absence of superimposed preeclampsia, pregnancymay continue
• Favorable cervix
• Labor • Completion of 40 weeks
• Usually good perinatal outcome irrespective ofantihypertensive drugs
• 49% ↓ MAP
• 34% with no change in MAP• Most poor outcomes were related to superimposedpreeclampsia
• Discontinue antihypertensive meds• Treat BP > 160/110 mmHg to keep DBP ≤105 mmHg
• In absence of superimposed preeclampsia, pregnancymay continue
• Favorable cervix
• Labor • Completion of 40 weeks
High Risk Chronic HTNHigh Risk Chronic HTN
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 49/52
gg
•Secondary hypertension
•Maternal age >40
•Duration HTN >15 years
•Target organ damage
•Previous perinatal loss•BP ≥180/110 mmHg
•Secondary hypertension
•Maternal age >40
•Duration HTN >15 years
•Target organ damage
•Previous perinatal loss
•BP ≥180/110 mmHg
High Risk Chronic HTNHigh Risk Chronic HTN
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 50/52
•Antihypertensive medication•Absent target organ damage
•Maintain BP 140-150/90-100 (140-160/90-105)•Target organ damage
•BP <140/90•Close monitoring
•Fetal evaluation at 28 (as early as 26) weeks
•Superimposed preeclampsia
•Hospitalization
•Delivery with GA ≥34 weeks
• Antihypertensive medication• Absent target organ damage
•Maintain BP 140-150/90-100 (140-160/90-105)•Target organ damage
•BP <140/90
• Close monitoring
•Fetal evaluation at 28 (as early as 26) weeks
• Superimposed preeclampsia
•Hospitalization
•Delivery with GA ≥34 weeks
Medication for BP ≥180/110Medication for BP ≥180/110
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 51/52
Drug Starting dose Max dose Acute treatment
Hydrazaline 5-10 mg IV q 20 min 30 mg
Labetalol 20-40 mg IV q 5-10 min 220 mg
Nifedipine 10-20 mg po q 30 min 50 mg
Long-term treatment
Methyldopa 250 mg bid 4 g/d
Labetalol 100 mg bid 2400 mg/d
Nifedipine 10 mg bid 120 mg/d
Thiazide diuretic 12.5 mg bid 50 mg/d
Superimposed PreeclampsiaSuperimposed Preeclampsia
8/10/2019 001 Hypertension in Pregnancy
http://slidepdf.com/reader/full/001-hypertension-in-pregnancy 52/52
• Incidence 4.7-52% depending on initial BP•Exacerbation of HTN
•At least ≥30 mm systolic or ≥15 mm diastolic
•Development of proteinuria
•≥500mg/24 h
•Exacerbation of preexisting proteinuria
•≥5 g /24 h
•↑ LFT's•↓ platelets
•↑ uric acid >6 mg/dL
• Development of symptoms
• Incidence 4.7-52% depending on initial BP•Exacerbation of HTN
• At least ≥30 mm systolic or ≥15 mm diastolic
•Development of proteinuria
•≥500mg/24 h
•Exacerbation of preexisting proteinuria•≥5 g /24 h
•↑ LFT's•↓ platelets
•↑ uric acid >6 mg/dL
•Development of symptoms